156 related articles for article (PubMed ID: 20162852)
21. HIV/Hepatitis B and C co-infection: pathogenic interactions, natural history and therapy.
Chung RT; Kim AY; Polsky B
Antivir Chem Chemother; 2001; 12 Suppl 1():73-91. PubMed ID: 11594692
[TBL] [Abstract][Full Text] [Related]
22. [Drug therapy of hepatitis B and C].
Färkkilä M
Duodecim; 2003; 119(6):519-29. PubMed ID: 12708339
[No Abstract] [Full Text] [Related]
23. American Association for the Study of Liver Diseases (AASLD)--56th Annual Meeting.
Phend C
IDrugs; 2006 Feb; 9(2):96-100. PubMed ID: 16523396
[No Abstract] [Full Text] [Related]
24. The impact of human immunodeficiency virus on viral hepatitis.
Mallet V; Vallet-Pichard A; Pol S
Liver Int; 2011 Jan; 31 Suppl 1():135-9. PubMed ID: 21205151
[TBL] [Abstract][Full Text] [Related]
25. Recent advances in the management and treatment of GI and hepatic diseases associated with HIV: Part 2.
Boyle BA
AIDS Read; 2001 Aug; 11(8):387-90, 397. PubMed ID: 11570261
[No Abstract] [Full Text] [Related]
26. Current issues in hepatitis C, HIV co-infection discussed at lunch and learn.
Monarch A
Surviv News (Atlanta Ga); 2002 Sep; ():14. PubMed ID: 12765135
[No Abstract] [Full Text] [Related]
27. [Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) coinfection: epidemiology, severity and recent therapeutic strategies].
Cacoub P; Pol S
Rev Med Interne; 2005 Apr; 26(4):267-70. PubMed ID: 15820560
[No Abstract] [Full Text] [Related]
28. HBV plus HCV, HCV plus HIV, HBV plus HIV.
Park JS; Saraf N; Dieterich DT
Curr Gastroenterol Rep; 2006 Feb; 8(1):67-74. PubMed ID: 16510037
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis C: who should be treated?
Campbell MS
Pharmacoepidemiol Drug Saf; 2006 Feb; 15(2):77-9. PubMed ID: 16447299
[No Abstract] [Full Text] [Related]
30. Viral hepatitis and HIV coinfection.
Sulkowski MS
J Hepatol; 2008 Feb; 48(2):353-67. PubMed ID: 18155314
[TBL] [Abstract][Full Text] [Related]
31. Providers face big challenge: HIV/HCV co-infection. Hepatitis B infection also problematic.
AIDS Alert; 2006 Aug; 21(8):85-7. PubMed ID: 16913040
[No Abstract] [Full Text] [Related]
32. IFN-alpha: therapeutic options in HIV and HIV/HCV, HIV/HBV dual infection.
Jablonowski H
Infection; 2003 Mar; 31(2):131-3. PubMed ID: 12749300
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B and C virus resistance to antiviral therapies--EASL-AASLD-APASL-ALEH-IASL conference.
Buti M
IDrugs; 2008 Apr; 11(4):239-41. PubMed ID: 18379952
[No Abstract] [Full Text] [Related]
34. Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection.
Sagnelli E; Pisaturo M; Martini S; Sagnelli C; Filippini P; Coppola N
Expert Opin Pharmacother; 2014 Jul; 15(10):1337-49. PubMed ID: 24773464
[TBL] [Abstract][Full Text] [Related]
35. [HVB and HVC infections in nephrology].
Pol S
Nephrologie; 2001; 22(6):321-2. PubMed ID: 11715611
[No Abstract] [Full Text] [Related]
36. HCV infection in the setting of HIV: prevalence, disease, treatment.
Laurence J
AIDS Read; 2006 Mar; 16(3):115-6. PubMed ID: 16538952
[No Abstract] [Full Text] [Related]
37. Antiviral therapies for hepatitis-related glomerulonephritis.
Kanaan N; Goffin E
Lancet; 2005 Jul 16-22; 366(9481):203. PubMed ID: 16023508
[No Abstract] [Full Text] [Related]
38. Serious neuropsychiatric adverse effects in a hepatitis C virus/hepatitis B virus/HIV-coinfected patient receiving bosentan and telaprevir.
Lê MP; Gervais A; Le Beller C; Long K; Larrouy L; Papy E; Mal H; Descamps D; Peytavin G
J Antimicrob Chemother; 2013 May; 68(5):1208-9. PubMed ID: 23335198
[No Abstract] [Full Text] [Related]
39. Antiviral therapy: quo vadis?
De Clercq E
Future Med Chem; 2010 Jul; 2(7):1049-53. PubMed ID: 21426154
[No Abstract] [Full Text] [Related]
40. Hepatitis and solid organ transplantation.
Pol S; Samuel D; Cadranel J; Legendre C; Bismuth H; Bréchot C; Kreis H
Transplant Proc; 2000 Mar; 32(2):454-7. PubMed ID: 10715478
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
